Dividend Policy & Shareholder Returns
History & Suspension: Coty Inc. (NYSE: COTY) historically paid a quarterly dividend of $0.125 per share (annualized $0.50) through early 2020 (www.streetinsider.com). However, on April 29, 2020, the Board suspended all common stock dividends as part of a COVID-era liquidity plan and in compliance with debt covenants (www.sec.gov) (www.sec.gov). No common dividends have been declared since FY2020 (www.sec.gov). As a result, Coty’s current dividend yield is 0.0% (www.macrotrends.net). Management indicated the suspension will continue until leverage improves substantially – originally targeting around 4× Net Debt/EBITDA (www.sec.gov), but more recently signaling an even stricter ~2× leverage goal before resuming payouts (za.investing.com). In other words, shareholders shouldn’t expect a dividend restoration in the near term as Coty prioritizes debt reduction.
Preferred Stock Overhang: Coty does pay a 9% annual dividend on its Convertible Series B Preferred Stock (issued in 2020 to KKR) (www.sec.gov). These cumulative preferred dividends (about $13.2 million per year) must be fully paid before any common dividend can be reinstated (www.sec.gov). Coty began paying the preferred dividends in cash once credit agreement restrictions lifted in 2021 (www.sec.gov). As of FY2025, ~$3.3 million in preferred dividends were accrued (unpaid) on the books (www.sec.gov), but the Board has been declaring and paying these quarterly (www.sec.gov). Notably, KKR exited its stake by end of 2021, selling most preferred shares or converting them to common; ~100,000 preferred shares (~$142 million worth) remain outstanding, mainly held by entities controlled by Coty’s Chairman Peter Harf (www.sec.gov) (www.sec.gov). Bottom line: common shareholders are effectively subordinated to this 9% preferred yield, and common dividends will remain on hold until leverage targets are met and all preferred dividends are current (www.sec.gov).
Share Buybacks: Despite the dividend freeze, Coty has pursued share repurchases as an alternative way to return capital. The Board authorized a total $1.1 billion in buybacks since 2016, with ~$796.8 million still available as of June 30, 2025 (www.sec.gov). Uniquely, Coty utilized forward stock purchase contracts to lock in large repurchases: for example, a $200 million forward in 2022 (settled in early 2024 for 27 million shares) and additional forwards of $196 million and $294 million initiated in 2022–2023 (www.sec.gov). These forwards allowed Coty to buy back shares systematically, but at a cost – they carry interest (SOFR + ~7% annually) and have “hedge adjustment” clauses if the stock falls (www.sec.gov) (www.sec.gov). Indeed, when COTY’s share price dipped below threshold levels in late 2024 and early 2025, Coty had to post $61.8 million and later $191.1 million in cash to counterparties (www.sec.gov) (www.sec.gov), effectively prepaying part of the buyback. This added volatility to cash flows and negated some debt reduction. The key takeaway for investors is that Coty has been aggressively reducing its float (e.g. 27 million shares repurchased in early 2024) but using debt-financed mechanisms to do so (www.sec.gov). While potentially accretive if the stock is undervalued, this strategy introduces leverage and cash timing risks – a point of caution given Coty’s debt load.
Yield Outlook: Given zero dividends and the above-average risk in Coty’s leveraged buyback approach, shareholder yield rests entirely on future price appreciation. Management has hinted that once net leverage sustainably hits ~2×, they will consider reinstating a dividend (za.investing.com) – but that likely won’t occur before 2026/27, if not later. In the meantime, current investors rely on Coty’s turnaround execution (and modest ongoing buybacks) for returns, rather than income distributions.
Leverage, Debt Maturities & Coverage
Debt Load: Coty carries a high debt burden, a legacy of past acquisitions (e.g. P&G Beauty in 2016) and restructuring. As of June 30, 2025, total debt was $4.008 billion (investors.coty.com). After offsetting $257 million cash, net debt stood at $3.751 billion (investors.coty.com). Thanks to earnings growth and asset sales, leverage has improved markedly in recent years – FY2025 adjusted EBITDA was $1.082 billion (investors.coty.com), putting net debt/EBITDA at 3.5× (investors.coty.com). This is down from leverage ratios well above 5× a few years prior. Management touts a ~“3× reduction in leverage” since 2020 (investors.coty.com) (investors.coty.com), aided by ~$280 million in annual free cash flow (investors.coty.com) and the partial sale of Wella (more below). Importantly, if we include Coty’s equity stake in Wella, the “economic” net debt falls to ~$2.75 billion (investors.coty.com) (investors.coty.com), effectively ~2.5× EBITDA. This metric recognizes the value of non-core assets that could be monetized to pay down debt.
Start collecting royalty checks before the first national payout.
Step 1
Learn the exact royalty play paying monthly checks
Step 2
Start with as little as $50 — get paid next month
Step 3
Position yourself before Wall Street moves in
Wella Stake: Coty retains a 25.8% stake in Wella Company (the professional hair care business it divested to KKR in 2020) (investors.coty.com). This stake was valued at about $1.0 billion as of mid-2025 (investors.coty.com). Management views it as a strategic asset that “supports economic deleveraging” (investors.coty.com). In practice, Coty could sell or IPO this stake to raise cash. Moody’s expects asset sale proceeds (presumably including Wella) to be used for debt reduction (za.investing.com). Thus, one potential catalyst before mid-2026 is whether Coty moves to monetize Wella – an action that could significantly cut net debt and perhaps meet the leverage target for resuming dividends. However, any sale timing is uncertain; Coty’s ability to fetch a good price for Wella (amid rising rates and a cautious M&A climate) remains an open question.
Maturity Wall – Action Needed by May 2026: Investors should note that a major debt maturity looms in calendar 2026. In fact, Coty has $1.17 billion coming due by April 2026 (www.sec.gov). This includes the remainder of Coty’s 5.00% Senior Secured Notes due April 2026, of which $650 million was outstanding before recent buybacks (investors.coty.com), and any drawings under Coty’s revolving credit facility. In late 2024 Coty took action – it fully redeemed its €180.3 million 4.75% Senior Notes due 2026 (investors.coty.com) and launched a tender to repurchase $250–300 million of the 2026 USD notes (investors.coty.com). Those steps, plus a new $750 million 2030 bond issuance (www.sec.gov) (www.sec.gov), will ease but not eliminate the 2026 refinancing need. As of early 2025, Moody’s warned that Coty still had ~$1.1 billion of 2026 notes to address and “will need to significantly utilize its ~$2 billion revolver” if not proactively refinanced (za.investing.com). In other words, before May 2026, Coty must secure funding or further rollovers for about a billion dollars of debt – hence the urgency in our report title. The company’s recent achievement of investment-grade ratings on two fronts in Sept 2024 (triggering covenant relief and collateral release on the secured notes) (www.sec.gov) (www.sec.gov) should help. Investment-grade status improves Coty’s access to debt markets and reduces restrictions on operations. Indeed, Coty’s credit ratings have been on an upswing: Moody’s upgraded Coty to Ba1 (one notch below IG) in Feb 2025 (za.investing.com), citing reduced leverage and a commitment to reach 2.0× net debt/EBITDA by 2025 (za.investing.com). However, not all agencies concur – Fitch rated Coty BB+ (still junk) and in early 2026 revised the outlook to negative, reflecting concerns about softer sales and the refinancing ahead (per industry reports).
Debt Structure & Future Maturities: Beyond 2026, Coty has a staggered debt maturity ladder: €500 million Senior Secured Notes due 2027 (4.50% coupon) (www.sec.gov), €500 million due 2028 (5.75% coupon) (www.sec.gov), $500 million due 2029 (4.75% coupon) (financialreports.eu), and $750 million due 2030 (6.625% coupon) (www.sec.gov). According to the 10-K, that translates to ~$585.7 million coming due in FY2027 and ~$1.493 billion in FY2029 (which includes the late-2028 and 2029 maturities) (www.sec.gov). There is effectively nothing maturing in FY2028 or FY2030, giving a breather in those years (www.sec.gov). The revolving credit facility (part of the 2018 Credit Agreement) provides liquidity in the interim; Coty had only minimal short-term borrowings on it at FY25 (just $10 million swingline loan) (www.sec.gov), but it could be drawn if needed to bridge the 2026 bond repayment (za.investing.com). Investors should watch for refinancing announcements in the next 12–18 months: successful refinancing of the 2026 notes well ahead of maturity (or further debt tenders) would be a positive catalyst, whereas any struggle to do so could pressure the stock and bond prices.
Interest Coverage: Despite high leverage, Coty’s interest coverage is currently solid. FY2025 net interest expense was $214.2 million (investors.coty.com) (investors.coty.com), implying ~5× coverage by adjusted EBITDA. Even on a GAAP basis, operating income covered interest ~4× in the most recent quarter. Moreover, most of Coty’s debt is fixed-rate (post refinancing, virtually all long-term debt is fixed aside from any revolver use) (www.sec.gov). This shields Coty from the worst of rising rates – a crucial advantage in today’s environment. However, one caveat is the floating-rate interest on the share repurchase forwards: Coty pays SOFR + ~7% on the ~$490 million notional of forwards still open as of FY25 (www.sec.gov) (www.sec.gov). This added roughly $22 million in interest costs in FY2025 and will fluctuate with rates (www.sec.gov). Nonetheless, the big picture is that Coty can comfortably cover its interest payments with current earnings, and interest expense actually fell in FY2025 vs prior year as debt was refinanced at better terms (investors.coty.com) (investors.coty.com). Achieving investment-grade ratings has already allowed Coty to lower its average coupon on new debt (e.g. 4.50–5.75% on recent euro notes, versus ~9% cost of the 2020 preferred equity) (www.sec.gov) (www.sec.gov). As long as Coty stabilizes its EBITDA, its interest burden should remain manageable. The risk, of course, is if EBITDA were to drop significantly (due to an economic downturn or business stumble) while ~$1 billion in debt needs rolling over – a scenario where coverage could deteriorate. For now, however, Coty’s fixed-charge coverage and liquidity buffer appear adequate (investors.coty.com) (investors.coty.com), especially given ~$2.8 billion in “economic” net debt (after Wella) and over $3 billion in equity capitalization to support refinancing efforts (investors.coty.com) (investors.coty.com).
Valuation & Comparables
Earnings Profile: Coty’s GAAP financials still reflect restructuring noise and heavy non-cash expenses, making traditional P/E ratios less meaningful. FY2025 reported net income was a loss of $381 million (due largely to goodwill amortization and one-time items) (www.sec.gov). However, on an adjusted basis Coty earned $188.8 million in net income (≈$0.50 adjusted EPS) (investors.coty.com) (investors.coty.com). This gap highlights significant amortization of intangibles from past acquisitions. For valuation, investors and analysts often look at EV/EBITDA or P/adjusted earnings to strip out those charges.
EV/EBITDA: Using FY2025 adjusted EBITDA of ~$1.08 billion (investors.coty.com) and the current enterprise value (market cap plus net debt), Coty trades around 9–10× EV/EBITDA (based on recent share prices in the high single digits). This multiple is at a discount to global beauty peers. For instance, industry leader L’Oréal and prestige peer Estée Lauder trade at higher multiples – L’Oréal’s EV/EBITDA is in the mid-teens and Estée’s exceeds 15× in part due to depressed 2024 earnings (www.macrotrends.net). On a price-to-sales basis, Coty’s ~$8 billion market cap is roughly 1.3× annual revenues, vs. ~2.5–3× for L’Oréal or Estée, reflecting Coty’s lower margins and higher leverage. It’s worth noting Coty’s adjusted EBITDA margin is about 18.4% (investors.coty.com), which still lags top-tier peers (Estée Lauder was ~21% pre-pandemic, L’Oréal ~19–20%). The upside case for Coty’s valuation is that as it expands margins and pays down debt, its multiple could re-rate closer to peers.
P/E and FCF Yield: If we annualize Coty’s adjusted EPS (~$0.50), the stock (around $8–9 as of Q1 2026) trades at ~16–18× forward “cash” earnings, which is relatively modest for a mid-cap consumer brand company. Free cash flow was ~$280 million in FY2025 (investors.coty.com), so the equity FCF yield is ~3.5–4% – not high, but this reflects heavy interest costs and some working capital build. As deleveraging continues, interest expense declines and one-off costs subside, Coty’s free cash flow could rise, improving that yield. However, equity investors must balance this potential with dilution risk: the remaining convertible preferred shares could convert into common stock (dilutive if stock appreciates significantly), and management’s aggressive buyback program is essentially shrinking the float with borrowed money, which could backfire if business results falter.
Comparables: Coty’s closest comparables span both mass and prestige beauty. Its Prestige division (fragrances, high-end cosmetics) aligns with Estée Lauder (market cap ~$39 B) and LVMH’s perfume/cosmetics arm, while its Consumer Beauty division (CoverGirl, Rimmel, etc.) competes with the likes of Revlon (now bankrupt) and smaller players. One relevant comp is Inter Parfums (a fragrance-focused company) which trades around 13× EBITDA with higher margins, highlighting Coty’s undervaluation if its turnaround holds. Another is e.l.f. Beauty, a fast-growing mass cosmetics brand (market cap ~$5 B) trading at over 30× earnings (www.macrotrends.net). Coty’s blended portfolio and debt load explain its discounted multiples. It’s essentially valued more like a struggling consumer brand company than a prestige beauty pure-play.
Sum-of-the-Parts Angle: The market may also be assigning a lower valuation due to conglomerate discount. Coty’s ongoing strategic review of its Consumer Beauty segment underscores this (www.axios.com). Announced in Sept 2025, the company is “weighing options” including possible sale or spin-off of its mass-market cosmetics brands (CoverGirl, Rimmel, Sally Hansen, Max Factor) which generate ~$1.2 billion in annual revenue (www.axios.com). If a sale materializes, it could bring in proceeds to slash debt and leave a higher-margin, pure-play prestige fragrance/cosmetics business. For example, a $1 billion sale (hypothetically ~0.8× sales multiple) would cut net debt by ~27%. The market might then reward Coty with a higher multiple more in line with prestige peers. On the other hand, no suitor may be willing to pay up for legacy drugstore makeup brands facing declining trends (www.axios.com). Thus, open questions remain on Coty’s portfolio value: Is the sum greater than the current whole? And can management execute a separation without eroding the remaining business? These uncertainties likely keep Coty’s valuation in check for now.
Risks, Red Flags & Open Questions
High Leverage and Refinancing Risk: Despite improvement, Coty’s absolute debt remains high, and upcoming maturities concentrate risk. The need to refinance ~$1.1 billion by spring 2026 is a clear risk factor (za.investing.com). If credit markets tighten or Coty’s performance falters before then, the company could face higher borrowing costs or difficulty rolling over debt. Notably, Fitch’s recent outlook downgrade to “negative” suggests concern about Coty’s execution and refinancing in a volatile market. Any hiccup in hitting FY2026 EBITDA targets (management expects a return to growth in 2H26 (investors.coty.com)) could raise Coty’s net leverage again, jeopardizing its newly earned investment-grade status and increasing refinancing costs. Investors should monitor debt-refinancing announcements closely – successful early refinancing of 2026 debt would reduce this risk, whereas delays or unfavorable terms would be red flags.
Controlling Shareholder & Governance: Coty is majority-owned by JAB Holding Company (the investment vehicle of the Reimann family). JAB and its affiliates beneficially own ~54% of Coty’s Class A common stock (www.sec.gov) (www.sec.gov), making Coty a “controlled company” under NYSE rules (www.sec.gov). This presents two implications: (1) JAB can steer major decisions (asset sales, M&A, dividends) that may not always align with minority shareholders’ interests (www.sec.gov). For instance, JAB’s priorities – such as long-term brand positioning or strategic acquisitions – could sacrifice near-term share price or delay shareholder returns. (2) Coty is exempt from certain corporate governance requirements (e.g. having fully independent boards) due to this status (www.sec.gov). While JAB has helped stabilize Coty (injecting capital via the KKR deal and installing CEO Sue Nabi), minority investors carry governance risk. Any future transactions between Coty and JAB (or its entities) could pose conflicts of interest (investors.coty.com). A current example is Chairman Peter Harf’s ownership of the remaining preferred shares – he effectively receives a 9% yield ahead of common shareholders (www.sec.gov) (www.sec.gov). Overall, the presence of a controlling stakeholder means minority investors must rely on JAB’s stewardship, which so far has been supportive (e.g. no evidence of extractive actions), but remains an inherent risk.
Strategic Uncertainties (Consumer Beauty Review): The fate of Coty’s consumer brands is an open question. The strategic review announced in late 2025 could result in a spinoff or sale of the entire $1.2 billion Consumer Beauty division (www.axios.com) (www.axios.com). This injects uncertainty into Coty’s mid-term strategy: will the company streamline to prestige only, or retain a diversified portfolio? A sale could deleverage Coty quickly but also remove a stable (if low-growth) cash-flow segment. Conversely, keeping the division means Coty must turn around legacy brands in a very tough mass-market environment (with competition from indie brands and retailer brands). The review itself implies that management sees more value or opportunity in these brands outside Coty’s current structure – but investors have limited visibility until a decision is made. If a transaction is announced, one must evaluate execution risk (can Coty separate supply chains, IP, etc. without disrupting operations?) and valuation risk (at what price and terms?). Until then, the overhang may weigh on Coty’s stock as the market dislikes uncertainty in core business composition.
Market & Operational Risks: Coty’s business has exposure to several broader risks: – Prestige Fragrance Boom – Sustainable? A major driver of Coty’s growth has been prestige fragrances (Burberry, Gucci, Kylie Skin, etc.), which saw a ~10% CAGR recently (investors.coty.com) (investors.coty.com). Fragrance demand has soared post-pandemic, but if this “fragrance boom” cools (due to fad or consumer spending shifts), Coty could see growth stall. Any sign of a fragrance oversupply or a pullback in luxury spending (especially in a recession) would hit Coty’s top line disproportionally. Retailer destocking and a slow U.S. cosmetics market already hurt Coty in 2025 (investors.coty.com), showing how quickly trends can change. – Mass Market Headwinds: On the flip side, Coty’s mass brands (CoverGirl, Rimmel) face secular declines – as management openly noted, these legacy names struggle against “prestige labels” and shifting consumer preferences (www.axios.com). Drugstore sales have been hurt by locked cabinets (theft prevention) and lower-income consumer pressures (www.axios.com). If these trends continue, the consumer beauty division could further erode in value, making a sale harder or resulting in ongoing write-downs. – Execution of Turnaround: CEO Sue Nabi’s team has implemented a cost-saving program (“All-In to Win” yielding $140 million savings in FY25) and reorganized Coty’s regional structure (investors.coty.com). While progress is evident in margins, execution risk remains – Coty needs to consistently launch “blockbuster” products (new fragrances like Boss Bottled, new categories like body mists) to drive growth (investors.coty.com). Any misstep in product innovation or marketing (an area Coty historically overspent on) could hamper the turnaround. Additionally, absorbing tech like AI in operations (investors.coty.com) and reshoring some production to the U.S. (investors.coty.com) are positive moves, but come with transition challenges. – Currency and Macro: Coty earns a significant portion of revenue in Europe and other regions; a strong U.S. dollar can reduce reported sales (FX dragged results in 2025 (investors.coty.com)). Inflation in raw materials or wages can squeeze margins if Coty cannot pass on costs. Conversely, economic downturns often hit beauty demand – though luxury beauty has proven resilient so far, it’s not immune. While Coty has partially hedged currency exposure (www.sec.gov), macro volatility is an ever-present risk.
Red Flags in Reporting: Investors should be aware of some complex or aggressive financial maneuvers in Coty’s recent history: – The use of derivative forward contracts for share buybacks, as discussed, added complexity and risk to the balance sheet. The need to post $191 million cash in early 2025 due to share price decline (www.sec.gov) was an unpleasant surprise, essentially a margin call on their buyback program. This kind of financial engineering is uncommon for a company still carrying substantial debt, and can be viewed as a red flag if not managed carefully. – Coty’s non-GAAP adjustments are significant – for example, adding back ~$495 million to go from GAAP net loss to adjusted net income in FY2025 (www.sec.gov). While much of this is justified (amortization, one-time costs), it means investors must continuously track the quality of earnings. Any inconsistency in what’s deemed “one-time” could mask underlying issues. – The KKR deal unwinding: Coty effectively issued $1 billion in preferred equity to KKR in 2020 and then had KKR exit by 2021 via conversions/sales (www.sec.gov). While this ultimately avoided diluting common shareholders massively at the bottom, it left Coty with the overhang of the preferred and also created a somewhat opaque sequence of events. The fact that an insider (Harf) ended up owning the remaining preferred shares could raise questions, although there’s no indication of impropriety.
Open Questions Going Forward: 1. Will Coty sell or spin-off Consumer Beauty? The outcome of the strategic review (CoverGirl and co.) is pending (www.axios.com). A sale could be transformative, but terms and timing are unknown. If nothing happens, does Coty double down on fixing that business or let it continue to drag? 2. When and how will the Wella stake be monetized? This $1 billion asset could significantly reduce debt (investors.coty.com). Is Coty waiting for a higher valuation or an IPO window? Investors should watch for any moves here, as it might coincide with the 2026 refinancing. 3. Can Coty resume growth in 2026? Management projects returning to like-for-like sales growth in the second half of FY2026 (investors.coty.com). If Q3–Q4 FY26 show reacceleration (helped by new product launches and China’s travel retail recovery), it would bolster confidence. Conversely, if growth sputters (e.g. continued U.S. weakness or no hit products), leverage metrics could stall, delaying the dividend comeback and risking credit outlook. 4. At what leverage will the dividend return? The company’s official stance is to remain suspended “until we approach Net Debt/Adj. EBITDA ~4×” (www.sec.gov), but Moody’s notes Coty likely won’t resume dividends until hitting 2× leverage and maintaining “at least good liquidity” (za.investing.com). This implies Coty might choose to keep deleveraging beyond the original target. Investors should be prepared for the possibility that even after May 2026, Coty could prioritize further debt paydown or buybacks over reinstating a cash dividend, especially if macro conditions are uncertain.
Conclusion
Coty has come a long way from its crisis in 2019–2020 – margins are improving, leverage is down, and the company has regained some investor confidence (investors.coty.com) (investors.coty.com). The stock’s valuation remains relatively depressed, suggesting skepticism that Coty can fully transform into a consistent growth story on par with its prestige peers. For current and prospective investors, the next year is pivotal. Action needed before May 22, 2026 essentially boils down to addressing that 2026 debt wall and executing on strategic decisions: – De-risk the balance sheet: A successful refinancing (or paydown via asset sales) of the 2026 maturities will remove a major overhang (za.investing.com). An opportunistic sale of the Wella stake or the Consumer Beauty unit could simultaneously deleverage the company and unlock value, potentially catalyzing a re-rating of Coty’s equity. – Sustain operational momentum: Hitting the FY2026 targets – sequential improvement in sales and EBITDA (investors.coty.com) – is critical to prove that Coty’s “five-year transformation” isn’t stalling out. This includes capitalizing on fragrance launches and expanding in high-growth channels (China, travel retail, e-commerce). – Balance sheet vs. shareholder returns: Investors will be watching how Coty balances further deleveraging needs with its appetite for buybacks. Given the still-high debt, many would prefer cash go to retiring bonds rather than repurchasing shares at this juncture. Management’s decisions here will signal their priorities (creditor vs. equity holder interests).
In summary, Coty offers a turnaround equity story with improving fundamentals, but also carries elevated financial risk and complexity. The stock could reward investors if leverage drops below ~3× and the dividend is eventually reinstated – such a scenario might justify multiple expansion toward peers. However, getting there requires navigating the 2026 refinancing, executing a possible divestiture, and continuing to reinvigorate brands in a competitive beauty market. With a dominant insider shareholder and a history of aggressive financial moves, Coty isn’t a low-risk play. Investors should remain vigilant through May 2026, ensuring that Coty’s actions (and results) align with the promising narrative. That date will likely mark a checkpoint by which we see if Coty has refinanced its debt smoothly and set the stage for the next chapter – one hopefully characterized by lower debt, renewed growth, and perhaps the return of the long-awaited dividend (www.sec.gov) (za.investing.com).
For informational purposes only; not investment advice.